1-5 of 5
Keywords: Management
Close
Follow your search
Access your saved searches in your account

Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles
Subject Area:
Oncology
Journal: Onkologie
Onkologie (2013) 36 (5): 295–302.
Published Online: 05 April 2013
... it is generally well tolerated, with most adverse events of mild to moderate severity and manageable, everolimus exhibits a distinct adverse event profile that warrants guidance for proper diagnostic and medical management. This guidance is particularly important given the potential for widespread long-term use...
Journal Articles
Subject Area:
Oncology
Journal: Onkologie
Onkologie (2011) 34 (4): 193–195.
Published Online: 23 March 2011
... or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Surgery Liver resection Management Squamous cell carcinoma (SCC...
Journal Articles
Subject Area:
Oncology
Journal: Onkologie
Onkologie (2010) 33 (5): 255–258.
Published Online: 21 April 2010
...Emel Yaman; Banu Ozturk; Ugur Coskun; Suleyman Buyukberber; Ali Osman Kaya; Ramazan Yildiz; Mustafa Benekli Background: Male breast cancer is an uncommon disease. Moreover, synchronous bilateral breast cancer is extremely rare in men. The management is still undefined, although it shows...
Journal Articles
Subject Area:
Oncology
Journal: Onkologie
Onkologie (1995) 18 (Suppl. 3): 46–50.
Published Online: 12 May 2009
... to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Ovarialkarzinom Risikofaktoren Prävention Screening Früherkennung Adnextumoren Management Onkologie 1995;18 (Sonderheft Früherkennung):46-50 H. G. Meerpohl...
Journal Articles
Subject Area:
Oncology
Journal: Onkologie
Onkologie (2009) 32 (3): 129–138.
Published Online: 16 February 2009
... tolerated, but inhibitory effects on the biological function of the targets in healthy tissue can result in specific treatment-related side effects, particularly with multitargeted agents. We offer some guidance on how to manage adverse events in cancer patients based on the range of options currently...